Supha Pharmachem (BOM:539561) E10: ₹4.45 (As of Sep. 2025)


BOM:539561 Supha Pharmachem Ltd BOM:539561
54 GF Score
Price ₹0.33
GF Value ₹1.53
Valuation Possible Value Trap
! 12 Warning Signs
View Full Analysis

What is Supha Pharmachem E10?

Supha Pharmachem BOM:539561 -2.94% 54 E10 is ₹4.45 as of Sep. 2025. GuruFocus rates BOM:539561 with a GF Score™ of 54/100 and a GF Value™ of ₹1.53 (Possible Value Trap). The stock has 12 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Supha Pharmachem's adjusted earnings per share data for the three months ended in Sep. 2025 was ₹0.100. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹4.45 for the trailing ten years ended in Sep. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-09), Supha Pharmachem's current stock price is ₹0.33. Supha Pharmachem's E10 for the quarter that ended in Sep. 2025 was ₹4.45. Supha Pharmachem's Shiller PE Ratio of today is 0.07.

During the past 11 years, the highest Shiller PE Ratio of Supha Pharmachem was 0.84. The lowest was 0.06. And the median was 0.26.


Supha Pharmachem  (BOM:539561) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Supha Pharmachem's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=0.33/4.45
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 11 years, the highest Shiller P/E Ratio of Supha Pharmachem was 0.84. The lowest was 0.06. And the median was 0.26.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Supha Pharmachem E10 Related Terms


Supha Pharmachem E10 Historical Data

* Premium members only.

The historical data trend for Supha Pharmachem's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Supha Pharmachem E10 Chart

Supha Pharmachem Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 4.73

Supha Pharmachem Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 5.01 4.73 4.57 4.45

BOM:539561 vs ZTS, UTHR: E10 Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Supha Pharmachem's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Supha Pharmachem Shiller PE Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Supha Pharmachem's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Supha Pharmachem's Shiller PE Ratio falls into.


BOM:539561
54GF Score
Supha Pharmachem Ltd BOM:539561
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Supha Pharmachem E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Supha Pharmachem's adjusted earnings per share data for the three months ended in Sep. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2025 (Change)*Current CPI (Sep. 2025)
=0.1/162.2892*162.2892
=0.100

Current CPI (Sep. 2025) = 162.2892.

Supha Pharmachem Quarterly Data

per share eps CPI Adj_EPS
201512 0.000 102.901 0.000
201603 0.000 102.518 0.000
201606 0.000 105.961 0.000
201609 0.000 105.961 0.000
201612 0.000 105.196 0.000
201703 0.000 105.196 0.000
201706 0.000 107.109 0.000
201709 0.000 109.021 0.000
201712 0.000 109.404 0.000
201803 0.000 109.786 0.000
201806 0.000 111.317 0.000
201809 0.000 115.142 0.000
201812 0.000 115.142 0.000
201903 0.000 118.202 0.000
201906 0.000 120.880 0.000
201909 0.000 123.175 0.000
201912 0.000 126.235 0.000
202003 0.004 124.705 0.005
202006 0.000 127.000 0.000
202009 0.001 130.118 0.001
202012 0.002 130.889 0.002
202103 0.005 131.771 0.006
202106 0.008 134.084 0.010
202109 0.019 135.847 0.023
202112 0.012 138.161 0.014
202203 -0.020 138.822 -0.023
202206 0.112 142.347 0.128
202209 0.212 144.661 0.238
202212 0.026 145.763 0.029
202303 -0.083 146.865 -0.092
202306 2.542 150.280 2.745
202309 4.523 151.492 4.845
202312 15.865 152.924 16.837
202403 -0.430 153.035 -0.456
202406 0.028 155.789 0.029
202409 0.028 157.882 0.029
202412 0.014 158.323 0.014
202503 -0.035 157.552 -0.036
202506 0.050 159.755 0.051
202509 0.100 162.289 0.100

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of ₹4.45 mean?
Supha Pharmachem (BOM:539561) has a E10 of ₹4.45 as of Sep. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Supha Pharmachem and its competitors.
Is Supha Pharmachem's E10 too high?
Supha Pharmachem's current E10 is ₹4.45. Overall, Supha Pharmachem has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Supha Pharmachem's E10 compare to ZTS and UTHR?
Supha Pharmachem's E10 of ₹4.45 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Drug Manufacturers company?
A good E10 depends on the Drug Manufacturers industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Supha Pharmachem and its competitors. Supha Pharmachem's current E10 is ₹4.45. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supha Pharmachem stock overvalued right now?
Based on GuruFocus' analysis, Supha Pharmachem (BOM:539561) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1.53, compared to a current price of ₹0.33 — trading 78.4% below its estimated fair value. The current E10 is ₹4.45. Supha Pharmachem's overall GF Score™ is 54/100 with 12 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Supha Pharmachem (BOM:539561), the current E10 is ₹4.45 as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Supha Pharmachem (BOM:539561) Overvalued in 2026?

Based on GuruFocus' analysis, Supha Pharmachem stock appears to be undervalued. The current stock price of ₹0.33 is trading 78.4% below its estimated GF Value™ of ₹1.53. GuruFocus considers Supha Pharmachem to be Possible Value Trap.

Key valuation signals for BOM:539561:

  • E10: ₹4.45
  • GF Value™: ₹1.53 vs. price of ₹0.33 (78.4% below fair value)
  • GF Score™: 54/100 with 12 warning signs

No single metric tells the full story. See the BOM:539561 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Supha Pharmachem Business Description

Address Saugbaug Road, Office No. 9, Behind Ravi Vihar Hotel, K Raheja Prime, Marol Industrial Estate, Andheri (East), Mumbai, MH, IND, 400059
Supha Pharmachem Ltd, formerly known as Remedium Lifecare Ltd, is engaged in the business of trading in API Intermediates (KSMs & CRMs) and various other raw materials used in API trading viz. Iso propyl Alcohol (IPA), Cyclohexane, DI Iso Propyl Amine (DIPA), Ethyl Acetate, Hydrazine Hydrate, Iso propyl Alcohol (IPA), Methylene Di Chloride, Potassium Carbonate Powder, Sodium Bi-Carbonate, Potassium Hydroxide Flakes, Sodium Chloride (Common Salt), Sodium Carbonate (SODA ASH), Amino isophthalic Acid, Tellurium(IV) Oxide, Grignard Reagent, Iodine, Selenium Metal Powder, Trimethyl Sulfoxonium Iodide (TMSI).
54GF Score

Get the complete analysis for BOM:539561

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹0.33
Price
₹1.53
GF Value